Novel inhibitor overcomes drug resistance in HER2-positive breast cancer
Drug Discovery World
JUNE 27, 2024
Korean scientists have found that HVH-2930, an innovative HSP90 inhibitor, demonstrates promising efficacy in inducing cancer cell apoptosis and overcoming treatment resistance in HER2-positive breast cancer. The study utilised both in vivo and in vitro methods to investigate HER2-positive breast cancer and potential treatments.
Let's personalize your content